2014
DOI: 10.1055/s-0034-1388347
|View full text |Cite
|
Sign up to set email alerts
|

Role of IGF1 in primary ovarian cancer – a study of the OVCAD European Consortium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…29 Another study also proved that IGF1 level was up-regulated in plasma of well-differentiated epithelial ovarian cancer. 30 As Zhang et al state that miR-130a expression was markedly reduced in cisplatin-resistant ovarian cancer cells. 31 Epigenetic alterations of HOX genes can be correlated with PCOS and consequently female infertility, which provide insight for novel treatments with epidrugs for this disease.…”
Section: Discussionmentioning
confidence: 99%
“…29 Another study also proved that IGF1 level was up-regulated in plasma of well-differentiated epithelial ovarian cancer. 30 As Zhang et al state that miR-130a expression was markedly reduced in cisplatin-resistant ovarian cancer cells. 31 Epigenetic alterations of HOX genes can be correlated with PCOS and consequently female infertility, which provide insight for novel treatments with epidrugs for this disease.…”
Section: Discussionmentioning
confidence: 99%
“…The dysregulation of IGF axis and its role in promoting cancer has been investigated for many years (14). The higher serum levels of IGF-1 and lower of IGFBP-3 are generally considered to be linked to an increased risk, progression and mortality of many malignant tumors, namely breast and ovarian cancers (8,15,16), prostate (17) and nasopharyngeal carcinomas (18). Moreover, IGF axis can induce tumor-associated lymphangiogenesis and promote lymphatic metastasis (19).…”
Section: Discussionmentioning
confidence: 99%
“…In our cohort, we aimed to make provision for tumor location, but no significant differences in the serum levels of IGF-1 and IGFBP-3 between separate anatomic sites were revealed. In contrast to the logically increased IGF-1 and decreased IGFBP-3 levels in many cancers, lots of conflicting results are known in HNSCC (8,(15)(16)(17)(18). Zhi et al have described the trend for downregulation IGF-1, 2 and up-regulation of IGFPB-3 mRNA in laryngeal cancer and Brady et al reported lower circulating levels of both IGF-1 and IGFBP-3 in patients with oral cancers suggesting different pathobiology of carcinoma in these particular locations (21,22).…”
Section: Discussionmentioning
confidence: 99%
“…The weak correlation between IGF-1 and CA-125 levels was also demonstrated in women with serous epithelial OC. No association between IGF-1 expression and either clinicopathological data was observed [24].…”
mentioning
confidence: 88%
“…In the FP6 European Project "OVCAD", 275 consecutive primary epithelial ovarian cancers were included from women after radical cytoreductive surgery and platinum-based chemotherapy [24]. The authors analyzed the predictive and prognostic role of circulatory IGF-1 levels in these patients and found that an increased plasma IGF-1 concentration was significantly more frequent in welldifferentiated epithelial OC.…”
mentioning
confidence: 99%